Karen M. Dobos

5.7k total citations
91 papers, 4.2k citations indexed

About

Karen M. Dobos is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Karen M. Dobos has authored 91 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 46 papers in Epidemiology and 33 papers in Molecular Biology. Recurrent topics in Karen M. Dobos's work include Tuberculosis Research and Epidemiology (59 papers), Mycobacterium research and diagnosis (40 papers) and vaccines and immunoinformatics approaches (12 papers). Karen M. Dobos is often cited by papers focused on Tuberculosis Research and Epidemiology (59 papers), Mycobacterium research and diagnosis (40 papers) and vaccines and immunoinformatics approaches (12 papers). Karen M. Dobos collaborates with scholars based in United States, Australia and India. Karen M. Dobos's co-authors include Nicole A. Kruh‐Garcia, John T. Belisle, Patrick J. Brennan, Carolina Mehaffy, Jeff Schorey, Lisa M. Wolfe, Jessica E. Prenni, C. Harold King, Angelo Izzo and E. Morton Bradbury and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Karen M. Dobos

87 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen M. Dobos United States	35	2.4k	2.2k	1.7k	1.0k	456	91	4.2k
Jordi B. Torrelles United States	39	2.6k 1.1×	2.0k 0.9×	1.3k 0.8×	1.3k 1.3×	415 0.9×	122	4.6k
Rui Appelberg Portugal	43	2.8k 1.2×	2.8k 1.3×	977 0.6×	2.4k 2.4×	493 1.1×	122	5.6k
Martine Gilleron France	41	1.8k 0.7×	2.0k 0.9×	1.7k 1.0×	1.9k 1.9×	298 0.7×	118	4.9k
Jérôme Nigou France	35	1.6k 0.7×	1.7k 0.8×	1.2k 0.7×	1.1k 1.1×	238 0.5×	89	3.5k
Selvakumar Subbian United States	33	2.1k 0.8×	1.5k 0.7×	993 0.6×	769 0.8×	509 1.1×	116	3.4k
Lee W. Riley United States	33	3.0k 1.2×	2.7k 1.2×	1.1k 0.6×	516 0.5×	1.4k 3.0×	65	4.4k
Maria Laura Gennaro United States	46	3.4k 1.4×	2.6k 1.2×	1.9k 1.1×	907 0.9×	888 1.9×	123	5.2k
Peter M. Keller Switzerland	31	888 0.4×	1.0k 0.5×	1.8k 1.1×	509 0.5×	551 1.2×	146	4.4k
Chantal de Chastellier France	36	1.6k 0.6×	1.8k 0.8×	1.3k 0.7×	820 0.8×	248 0.5×	58	4.2k
Nathalie Winter France	33	1.6k 0.7×	1.3k 0.6×	699 0.4×	1.6k 1.6×	262 0.6×	72	3.4k

Countries citing papers authored by Karen M. Dobos

Since Specialization

Citations

This map shows the geographic impact of Karen M. Dobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen M. Dobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen M. Dobos more than expected).

Fields of papers citing papers by Karen M. Dobos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen M. Dobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen M. Dobos. The network helps show where Karen M. Dobos may publish in the future.

Co-authorship network of co-authors of Karen M. Dobos

This figure shows the co-authorship network connecting the top 25 collaborators of Karen M. Dobos. A scholar is included among the top collaborators of Karen M. Dobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen M. Dobos. Karen M. Dobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mehaffy, Carolina, et al.. (2025). Systematic review of innate immune responses against Mycobacterium tuberculosis complex infection in animal models. Frontiers in Immunology. 15. 1467016–1467016. 2 indexed citations

Dzieciątkowska, Monika, et al.. (2025). Establishment of minimum protein standards for Mycobacterium tuberculosis-derived extracellular vesicles through comparison of EV enrichment methods. PubMed. 1(1). 3–3.

Mehaffy, Carolina, Megan Lucas, Digby F. Warner, et al.. (2024). Modulation of riboflavin biosynthesis and utilization in mycobacteria. Microbiology Spectrum. 12(8). e0320723–e0320723. 3 indexed citations

Moro, Ruth N., Carolina Mehaffy, Prithwiraj De, et al.. (2024). Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection. The Journal of Infectious Diseases. 230(5). 1271–1278.

Ramírez, Gabriela, et al.. (2024). Investigating the lipid profile of Anopheles stephensi mosquitoes across developmental life stages. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 52. 101312–101312. 1 indexed citations

Cantera, Jason L., Roger Peck, Emmanuel Moreau, et al.. (2022). Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis. PLoS ONE. 17(9). e0274415–e0274415. 5 indexed citations

Honda, Jennifer R., Tamara Hess, Pitchaimani Kandasamy, et al.. (2019). Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37. American Journal of Respiratory Cell and Molecular Biology. 62(3). 354–363. 13 indexed citations

Mehaffy, Carolina, et al.. (2019). Protein profile of different cellular fractions from Mycobacterium tuberculosis strains after exposure to isoniazid. SHILAP Revista de lepidopterología. 24. 103953–103953. 2 indexed citations

Mehaffy, Carolina, et al.. (2018). Biochemical Characterization of Isoniazid-resistant Mycobacterium tuberculosis: Can the Analysis of Clonal Strains Reveal Novel Targetable Pathways?. Molecular & Cellular Proteomics. 17(9). 1685–1701. 20 indexed citations

10.

Harriff, Melanie J., Lisa M. Wolfe, Gwendolyn Swarbrick, et al.. (2017). HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells. Scientific Reports. 7(1). 4622–4622. 30 indexed citations

11.

Perley, Casey C., Eva M. Click, Karen M. Dobos, et al.. (2014). The Human Antibody Response to the Surface of Mycobacterium tuberculosis. PLoS ONE. 9(6). e98938–e98938. 36 indexed citations

12.

Kruh‐Garcia, Nicole A., et al.. (2013). Antigen 85 variation across lineages of Mycobacterium tuberculosis—Implications for vaccine and biomarker success. Journal of Proteomics. 97. 141–150. 20 indexed citations

13.

Grover, Ajay, JoLynn Troudt, Linda Izzo, et al.. (2011). Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis. Tuberculosis. 92(1). 105–111. 19 indexed citations

14.

Kruh‐Garcia, Nicole A., JoLynn Troudt, Angelo Izzo, Jessica E. Prenni, & Karen M. Dobos. (2010). Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo. PLoS ONE. 5(11). e13938–e13938. 173 indexed citations

15.

Mehaffy, Carolina, Ann M. Hess, Jessica E. Prenni, et al.. (2010). Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. PROTEOMICS. 10(10). 1966–1984. 40 indexed citations

16.

Tanne, Antoine, Bo Ma, Frédéric Boudou, et al.. (2009). A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis. The Journal of Experimental Medicine. 206(10). 2205–2220. 86 indexed citations

17.

Sieling, Peter A., Preston J. Hill, Karen M. Dobos, et al.. (2008). Conserved Mycobacterial Lipoglycoproteins Activate TLR2 but Also Require Glycosylation for MHC Class II-Restricted T Cell Activation. The Journal of Immunology. 180(9). 5833–5842. 26 indexed citations

18.

Marques, Maria Angela M., Ana Gisele C. Neves‐Ferreira, Richard H. Valente, et al.. (2008). Deciphering the proteomic profile of Mycobacterium leprae cell envelope. PROTEOMICS. 8(12). 2477–2491. 39 indexed citations

19.

Hmama, Zakaria, Khalid Sendide, Amina Talal, et al.. (2004). Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1α,25-dihydroxyvitamin D3–phosphoinositide 3-kinase pathway. Journal of Cell Science. 117(10). 2131–2140. 123 indexed citations

20.

Gehring, Adam J., Karen M. Dobos, John T. Belisle, Clifford V. Harding, & W. Henry Boom. (2004). Mycobacterium tuberculosis LprG ( Rv1411c ): A Novel TLR-2 Ligand That Inhibits Human Macrophage Class II MHC Antigen Processing. The Journal of Immunology. 173(4). 2660–2668. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact